Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis
Abstract
Calcific aortic stenosis (AS) is the most common form of valve disease in the Western world and affects over 2.5 million individuals in North America. Despite the large burden of disease, there are no medical treatments to slow the development of AS, due at least in part to our incomplete understanding of its causes. The Cohorts for Heart and Aging Research in Genetic Epidemiology extra-coronary calcium consortium reported a genome-wide...
Paper Details
Title
Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis
Published Date
Jun 1, 2016
Journal
Volume
57
Issue
6
Pages
917 - 924
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History